Trial intelligence / Profile preview

Statins added to ARB/ACE inhibitor therapy in hypertensive chronic kidney disease

NL-OMON28420Not yet recruiting

Sponsor
University Medical Center Utrecht
Start
Aug 2009
Countries
1
01

Overview

Trial in chronic kidney disease (CKD) and hypertension (HTN) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Suppression of sympathetic nerve activity. Planned start Aug 2009; status: not yet recruiting.

02

Conditions

chronic kidney disease (CKD)hypertension (HTN)

Beyond the preview

Go deeper on NL-OMON28420.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28420.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call